I feel that 48c was way too high. they should have priced it closer to 40c. underwriters not feeling too good now...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025